Product Code: VMR11219466
The global demand for Toxicity Testing Outsourcing Market is presumed to reach the market size of nearly USD 18.8 BN by 2030 from USD 6.44 BN in 2022 with a CAGR of 12.64% under the study period 2023 - 2030.
Toxicity Testing Outsourcing is a service that helps companies test the toxicity of their products. The company tests a product for its toxicity by using an in vitro assay. The assay is done by exposing cells to the product and then measuring the toxic effects on the cells over time. This service can be used to test the toxicity of products such as cosmetics, drugs, pesticides and other medical devices. These services can also be used to test for genotoxic potential or mutagenicity in order to ensure the safety of consumer products.
MARKET DYNAMICS:
Toxicity testing outsourcing is a highly prospective market with huge growth potential. It is driven by factors like growing demand for quality toxicology data, increasing awareness about environmental pollution, and reducing risk. The toxicity testing outsourcing market is anticipated to develop due to the increased interest of pharmaceutical companies in the research and development of drugs. Moreover, animal testing has been facing opposition from environmentalists, leading to more demand for these services. However, the market might face a few growth restraints due to the complexity of toxicology testing and the lack of standardization in current practices.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of toxicity testing outsourcing. The growth and trends of toxicity testing outsourcing industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the toxicity testing outsourcing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Method
By GLP Type
By End-Use
- Pharmaceutical And Biopharmaceutical Companies
- Academic And Research Institutes
- Other
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the Toxicity Testing Outsourcing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the toxicity testing outsourcing market include Euro fins Scientific, SGS SA, Charles River Laboratories, Thermo Fisher Scientific Inc, Intertek Group plc, Catalent Inc, ICON plc, Med pace, Labcorp Drug Development, Wuxi AppTec. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . TOXICITY TESTING OUTSOURCING - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Method
- 3.7.2 Market Attractiveness Analysis By GLP Type
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL TOXICITY TESTING OUTSOURCING MARKET ANALYSIS BY METHOD
- 6.1 Overview by Method
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Method
- 6.4 In Vitro Historic and Forecast Sales by Regions
- 6.5 In Vivo Historic and Forecast Sales by Regions
7 . GLOBAL TOXICITY TESTING OUTSOURCING MARKET ANALYSIS BY GLP TYPE
- 7.1 Overview by GLP Type
- 7.2 Historical and Forecast Data
- 7.3 Analysis by GLP Type
- 7.4 GLP Historic and Forecast Sales by Regions
- 7.5 Non GLP Historic and Forecast Sales by Regions
8 . GLOBAL TOXICITY TESTING OUTSOURCING MARKET SALES ANALYSIS BY END-USE
- 8.1 Overview by End-use
- 8.2 Historical and Forecast Data
- 8.3 Analysis by End-use
- 8.4 Pharmaceutical And Biopharmaceutical Companies Historic and Forecast Sales by Regions
- 8.5 Academic And Research Institutes Historic and Forecast Sales by Regions
- 8.6 Other Historic and Forecast Sales by Regions
9 . GLOBAL TOXICITY TESTING OUTSOURCING MARKET SALES ANALYSIS BY GEOGRAPHY
- 9.1. Regional Outlook Sales Analysis
- 9.2. Introduction Sales Analysis
- 9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
- 9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
- 9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
- 9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
- 9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis
10 . COMPETITIVE LANDSCAPE OF THE TOXICITY TESTING OUTSOURCING COMPANIES
- 10.1. Toxicity Testing Outsourcing Market Competition
- 10.2. Partnership/Collaboration/Agreement
- 10.3. Merger And Acquisitions
- 10.4. New Product Launch
- 10.5. Other Developments
11 . COMPANY PROFILES OF TOXICITY TESTING OUTSOURCING INDUSTRY
- 11.1. Top 10 Company Share Analysis
- 11.2. Market Concentration Rate
- 11.3. Euro fins Scientific
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
- 11.4. SGS SA
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
- 11.5. Charles River Laboratories
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
- 11.6. Thermo Fisher Scientific Inc
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
- 11.7. Intertek Group plc
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
- 11.8. Catalent Inc
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
- 11.9. ICON plc
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
- 11.10. Med pace
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
- 11.11. Labcorp Drug Development
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
- 11.12. Wuxi AppTec.
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies